A new route toward 4-substituted pyrazino[2,1-b]quinazoline-3,6-dione systems. Total synthesis of glyantrypine

Journal of Organic Chemistry

Volumn 65, Issue 6, 2000, Pages 1743-1749

  Cledera, Pilar ^a   Avendaño, Carmen ^a   Menéndez, J Carlos ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FISCALIN B; FUMIQUINAZOLINE A; GLYANTRYPINE; N ACETYLARDEEMIN; QUINAZOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; DEACETYLATION; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; REACTION ANALYSIS; STEREOCHEMISTRY;

DRUG RESISTANCE, MULTIPLE; MAGNETIC RESONANCE SPECTROSCOPY; QUINAZOLINES; STEREOISOMERISM; TRYPTOPHAN;

EID: 0034708411     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo991626e     Document Type: Article

References (38)

1. (a) Wong, S.-M.; Musza, L. L.; Kydd, G. C.; Kullnig, R.; Gillum, A. M.; Cooper, R. J. Antibiotics 1993, 46, 545.
2. (b) Fujimoto, H.; Negishi, E.; Yamaguchi, K.; Nishi, N.; Yamazaki, M. Chem. Pharm. Bull. 1996, 44, 1843.
3. (a) Numata, A.; Takahashi, C.; Matsushita, T.; Miyamoto, T.; Kawai, K.; Usami, Y.; Matsumura, E.; Inoue, M.; Ohishi, H.; Shingu, T. Tetrahedron Lett. 1992, 33, 1621.
4. (b) Takahashi, C.; Matsushita, T.; Doi, M.; Minoura, K.; Shingu, T.; Kumeda, Y.; Numata A. J. Chem. Soc., Perkin Trans. 1 1995, 2345.
5. Penn, J.; Mantle, P. G.; Bilton, J. N.; Sheppard, R. N. J. Chem. Soc., Perkin Trans. 1 1992, 1495.
6. (a) Karwowski, J. P.; Jackson, M.; Rasmussen, R. R.; Humphrey, P. E.; Poddig, J. B.; Kohl, W. L.; Scherr, M. H.; Kadam, S.; McAlpine, J. B. J. Antibiot. 1993, 46, 374.
7. (b) Hochlowski, J. E.; Mullally, M. M.; Spanton, S. G.; Whittern, D. N.; Hill, P.; McAlpine, J. B. J. Antibiot. 1993, 46, 380.
8. Liesch, J. M.; Hensens, O. D.; Springer, J. P.; Chang, R. S. L.; Lotti, V. J. J. Antibiot. 1985, 58, 1638.
9. (a) Isolation and structure: Mehta, D. R.; Naravane, J. S.; Desai, R. M. J. Org. Chem. 1963, 28, 445.
10. (b) Absolute configuration: Joshi, B. S.; Newton, M. G.; Lee, D. W.; Barber, A. D.; Pelletier, S. W. Tetrahedron: Asymmetry 1996, 7, 25.
11. (a) Ma, Z. Z.; Hano, Y.; Nomura, T.; Chen, Y. J. Heterocycles 1997, 46, 541.
12. (b) Ma, Z. Z.; Hano, Y.; Nomura, T.; Chen, Y. J. Heterocycles 1999, 51, 1883.
13. (a) Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells; Roninson, I. B., Ed.; Plenum Press: New York, 1991.
14. (b) Kane, S. E. Adv. Drug Res. 1996, 28, 181.
15. Méndez-Vidal, C.; Rodríguez de Quesada, A. Cancer Lett. 1998, 132, 45.
16. (a) Rajappa, S.; Advani, B. G. Tetrahedron 1973, 29, 1299.
17. (b) Rajappa, S.; Advani, B. G. J. Chem. Soc., Perkin Trans. 1 1974, 2122.
18. Bock, M. G.; DiPardo, R. M.; Pitzenberger, S. M.; Homnick, C. F.; Springer, J. P.; Freidinger, R. M. J. Org. Chem. 1987, 52, 1644.
19. (a) Takeuchi, H.; Hagiwara, S.; Eguchi, S. Tetrahedron 1989, 45, 6375.
20. For some applications of this method to the synthesis of natural products, see: (b) Marsden, S. P.; Depew, K. M.; Danishefsky, S. J. J. Am. Chem. Soc. 1994, 116, 11143 (total synthesis of N-acetylardeemin).
21. (c) He, F.; Snider, B. B. Synlett 1997, 483 (total synthesis of ent-fumiquinazoline G).
22. (d) He, F.; Foxman, B. M.; Snider, B. B. J. Am. Chem. Soc. 1998, 120, 6417 (total synthesis of asperlicin and asperlicin C).
23. Related method: (a) Molina, P.; Alajarin, M.; Vidal, A.; Foces-Foces, M. C.; Hernández-Cano, F. Tetrahedron 1989, 45, 4263. (b) Villalgordo, J. M.; Obrecht, D.; Chucholowsky, A. Synlett 1998, 1405.
24. Related method: (a) Molina, P.; Alajarin, M.; Vidal, A.; Foces- Foces, M. C.; Hernández-Cano, F. Tetrahedron 1989, 45, 4263. (b) Villalgordo, J. M.; Obrecht, D.; Chucholowsky, A. Synlett 1998, 1405.
25. For problems found in this type of deprotection, see: Buenadicha, F. L.; Bartolomé, M. T.; Aguirre, M. J.; Avendaño, C.; Söllhuber, M. Tetrahedron: Asymmetry 1998, 9, 483.
26. Treatment with piperidine to give an amidine carboxamide, followed by silica gel-induced cyclization to a 2-aminomethyl-3-carboxymethyl-3,4-dihydroquinazolin-4-one and then to the tricyclic system: He, F.; Snider, B. B. J. Org. Chem. 1999, 64, 1397. For an alternative method to achieve this cyclization, in the context of a synthesis of the alkaloid (-)-alantrypinone, see: Hart, D. J.; Magomedov, N. Tetrahedron Lett. 1999, 40, 5429.
27. Treatment with piperidine to give an amidine carboxamide, followed by silica gel-induced cyclization to a 2-aminomethyl-3- carboxymethyl-3,4-dihydroquinazolin-4-one and then to the tricyclic system: He, F.; Snider, B. B. J. Org. Chem. 1999, 64, 1397. For an alternative method to achieve this cyclization, in the context of a synthesis of the alkaloid (-)-alantrypinone, see: Hart, D. J.; Magomedov, N. Tetrahedron Lett. 1999, 40, 5429.
28. These intermediates were initially assigned as 2-aminomethyl-3-carboxymethyl-3,4-dihydroquinazolin-4-ones during the total synthesis of fumiquinazoline G and fiscalin B: Wang, H.; Ganesan, A. J. Org. Chem. 1998, 63, 2432.
29. For the application of these conditions to the synthesis of oxazole derivatives from β-ketoamides, see: Wipf, P.; Miller, C. P. J. Org. Chem. 1993, 58, 3604.
30. Sheehan, J. C.; Ledis, S. L. J. Am. Chem. Soc. 1973, 95, 875.
31. Use of higher pressures (4 atm) favors the cyclization of compounds 4 to the corresponding 2,5-piperazinediones.
32. Bailey, P. D.; Collier, I. D.; Morgan, K. M. In Comprehensive Functional Group Chemistry; Moody, C. J., Ed.; Katritzky, A. R., Meth-Cohn, O., Rees, C. W., General Eds.; Pergamon Press: Elmsforg, NY, 1995; chapter 5.04
33. Pihko, P. M.; Koskinen, A. M. P. J. Org. Chem. 1998, 63, 92.
34. Kometani, T.; Fitz, T.; Watt, D. S. Tetrahedron Lett. 1986, 27, 919.
35. (a) Butler, D. E.; Leonard, J. D.; Caprathe, B. W.; L'Italien, Y. J.; Pavia, M. R.; Hershenson, F. M.; Poschel, P. H.; Marriott, J. G. J. Med. Chem. 1987, 30, 498.
36. (b) Pavia, M. R.; Moos, W. H.; Hershenson, F. M. J. Org. Chem. 1990, 55, 560.
37. González-Muñiz, R.; García-López, M. T.; Gómez-Monterrey, I.; Herranz, R.; Jimeno, M. L.; Suärez-Gea, M. L.; Johansen, N. L.; Madsen, K.; Thøgersen, H.; Suzdak, P. J. Med. Chem. 1995, 38, 1015.
38. Prepared from anthranilic acid as described in Cledera, P.; Avendano, C.; Menéndez, J. C. Tetrahedron 1998, 54, 12349.